US Health Agency Calls for Inquiry into Alzheimer’s Drug Review
The acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug. Dr. Janet Woodcock announced the extraordinary step …